Klaus HellmannKlifovet AG
CEO

GOLD DIGITAL INNOVATION PARTNER

MEET OUR TEAM
Klaus Hellmann
Dr Rike BrunnerVIEW OUR SESSION
This panel with provide the audience with strategic guidance on how to approach the regulatory pathways for animal health.
- Regulation of biologics in the US (i.e. jurisdiction between CVB and CVM – and why you might want one or the other)
- New requirements from CVB regarding immunotherapeutics (VSM 800.126)
- Medical device regulation – or lack thereof
VIEW OUR USEFUL RESOURCES
Be sure not to miss the pre-event webinar session: Global Development – navigating EU and North American Animal Health approvals
Preclinical Studies Services
Regulatory Affairs Services
Quality Assurance Services
Clinical Studies Services
Data Management Services